IV-361
IV-361 是一种口服有效，选择性的 CDK7 抑制剂 (Ki≤50 nM)。IV-361 具有抗肿瘤作用 (US20190256531A1)。
此产品仅用于科学研究，我们不为任何个人用途提供产品和服务
-
包装价格促销价数量
-
5mg￥11337.009070.00- +
-
10mg￥17625.0014100.00- +
已选
0
种
0
瓶
金额:
￥0.00
首页
收藏
- 货号: ajcx35724
- CAS: 2055741-39-2
- 别名:
- 分子式: C23H32FN5O2Si
- 分子量: 457.62
- 纯度: ＞98%
- 溶解度: DMSO : 90 mg/mL (196.67 mM; Need ultrasonic)
- 储存: Store at -20°C
- 库存: 现货
Background
IV-361 is an orally active and selective CDK7 inhibitor (Ki≤50 nM). IV-361 has anti-cancer activity (US20190256531A1)[1].
IV-361 has less inhibition on CDK2 (Ki≥1000 nM) or PLK1 (Ki≥5000 nM)[1]. IV-361 exhibits excellent IL-2 and IL-17 production inhibitory activity (all IC50≤100 nM) in periphery blood mononuclear cell (PBMC)[1]. IV-361 exhibits excellent HCT-116 cell growth inhibitory activity (GI50≤100 nM)[1].
IV-361 (25 mg/kg/day; orally) exhibits 46% or more rate of suppression of tumor volume in female BALB nude mice with HCT-116[1].
[1]. Noriaki Iwase, et al. Substituted dihydropyrrolopyrazole derivative. US20190256531A1.
